ARCHIVES

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate Confirms Sullivan, Who Fires 100 HHS Political Appointees: Wyngaarden Still On Job

March 10, 1989

Cancer Genome Atlas Researchers Link Cell Metabolism Pathways To Disease Aggressiveness

July 26, 2013

Workers Ignorant Of Benzidine Risk, Union tells Congress

April 3, 1987

Senate Appropriations Include Cancer Control, Training Money, But Very Little for Construction

July 8, 1988

Nexavar Improves PFS In Phase III Trial

January 25, 2013

DeVita: “The War On Cancer Is Dead”

June 11, 2010